128 related articles for article (PubMed ID: 22567129)
1. Protocadherin-18 is a novel differentiation marker and an inhibitory signaling receptor for CD8+ effector memory T cells.
Vazquez-Cintron EJ; Monu NR; Burns JC; Blum R; Chen G; Lopez P; Ma J; Radoja S; Frey AB
PLoS One; 2012; 7(5):e36101. PubMed ID: 22567129
[TBL] [Abstract][Full Text] [Related]
2. Suppression of proximal T cell receptor signaling and lytic function in CD8+ tumor-infiltrating T cells.
Monu N; Frey AB
Cancer Res; 2007 Dec; 67(23):11447-54. PubMed ID: 18056473
[TBL] [Abstract][Full Text] [Related]
3. The Inhibitory Signaling Receptor Protocadherin-18 Regulates Tumor-Infiltrating CD8
Frey AB
Cancer Immunol Res; 2017 Oct; 5(10):920-928. PubMed ID: 28874354
[TBL] [Abstract][Full Text] [Related]
4. Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic function.
Koneru M; Schaer D; Monu N; Ayala A; Frey AB
J Immunol; 2005 Feb; 174(4):1830-40. PubMed ID: 15699109
[TBL] [Abstract][Full Text] [Related]
5. CD8
Mellouk A; Bobé P
FASEB J; 2019 Mar; 33(3):3225-3236. PubMed ID: 30383448
[TBL] [Abstract][Full Text] [Related]
6. Defective adhesion in tumor infiltrating CD8+ T cells.
Koneru M; Monu N; Schaer D; Barletta J; Frey AB
J Immunol; 2006 May; 176(10):6103-11. PubMed ID: 16670319
[TBL] [Abstract][Full Text] [Related]
7. Human effector T cells derived from central memory cells rather than CD8(+)T cells modified by tumor-specific TCR gene transfer possess superior traits for adoptive immunotherapy.
Wu F; Zhang W; Shao H; Bo H; Shen H; Li J; Liu Y; Wang T; Ma W; Huang S
Cancer Lett; 2013 Oct; 339(2):195-207. PubMed ID: 23791878
[TBL] [Abstract][Full Text] [Related]
8. Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.
Moogk D; Zhong S; Yu Z; Liadi I; Rittase W; Fang V; Dougherty J; Perez-Garcia A; Osman I; Zhu C; Varadarajan N; Restifo NP; Frey AB; Krogsgaard M
J Immunol; 2016 Jul; 197(2):644-54. PubMed ID: 27271569
[TBL] [Abstract][Full Text] [Related]
9. CD8(+) tumor-infiltrating T cells are deficient in perforin-mediated cytolytic activity due to defective microtubule-organizing center mobilization and lytic granule exocytosis.
Radoja S; Saio M; Schaer D; Koneru M; Vukmanovic S; Frey AB
J Immunol; 2001 Nov; 167(9):5042-51. PubMed ID: 11673513
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of Wnt/ß-catenin pathway in human CD8+ T lymphocytes from blood and lung tumors leads to a shared young/memory phenotype.
Forget MA; Huon Y; Reuben A; Grange C; Liberman M; Martin J; Mes-Masson AM; Arbour N; Lapointe R
PLoS One; 2012; 7(7):e41074. PubMed ID: 22859966
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IL-21 signaling by suppressor of cytokine signaling-1 (SOCS1) in CD8(+) T lymphocytes.
Gagnon J; Ramanathan S; Leblanc C; Ilangumaran S
Cell Signal; 2007 Apr; 19(4):806-16. PubMed ID: 17126530
[TBL] [Abstract][Full Text] [Related]
12. Functional properties and lineage relationship of CD8+ T cell subsets identified by expression of IL-7 receptor alpha and CD62L.
Bachmann MF; Wolint P; Schwarz K; Jäger P; Oxenius A
J Immunol; 2005 Oct; 175(7):4686-96. PubMed ID: 16177116
[TBL] [Abstract][Full Text] [Related]
13. Differential in vivo persistence of two subsets of memory phenotype CD8 T cells defined by CD44 and CD122 expression levels.
Walzer T; Arpin C; Beloeil L; Marvel J
J Immunol; 2002 Mar; 168(6):2704-11. PubMed ID: 11884436
[TBL] [Abstract][Full Text] [Related]
14. Detection and characterization of a novel subset of CD8⁺CD57⁺ T cells in metastatic melanoma with an incompletely differentiated phenotype.
Wu RC; Liu S; Chacon JA; Wu S; Li Y; Sukhumalchandra P; Murray JL; Molldrem JJ; Hwu P; Pircher H; Lizée G; Radvanyi LG
Clin Cancer Res; 2012 May; 18(9):2465-77. PubMed ID: 22307139
[TBL] [Abstract][Full Text] [Related]
15. SHP-1 in T cells limits the production of CD8 effector cells without impacting the formation of long-lived central memory cells.
Fowler CC; Pao LI; Blattman JN; Greenberg PD
J Immunol; 2010 Sep; 185(6):3256-67. PubMed ID: 20696858
[TBL] [Abstract][Full Text] [Related]
16. Reversing tumor immune suppression with intratumoral IL-12: activation of tumor-associated T effector/memory cells, induction of T suppressor apoptosis, and infiltration of CD8+ T effectors.
Kilinc MO; Aulakh KS; Nair RE; Jones SA; Alard P; Kosiewicz MM; Egilmez NK
J Immunol; 2006 Nov; 177(10):6962-73. PubMed ID: 17082611
[TBL] [Abstract][Full Text] [Related]
17. Neural-Cadherin Influences the Homing of Terminally Differentiated Memory CD8 T Cells to the Lymph Nodes and Bone Marrow.
Kim KH; Choi A; Kim SH; Song H; Jin S; Kim K; Jang J; Choi H; Jung YW
Mol Cells; 2021 Nov; 44(11):795-804. PubMed ID: 34819396
[TBL] [Abstract][Full Text] [Related]
18. ITK and IL-15 support two distinct subsets of CD8+ T cells.
Dubois S; Waldmann TA; Müller JR
Proc Natl Acad Sci U S A; 2006 Aug; 103(32):12075-80. PubMed ID: 16880398
[TBL] [Abstract][Full Text] [Related]
19. The basis of distinctive IL-2- and IL-15-dependent signaling: weak CD122-dependent signaling favors CD8+ T central-memory cell survival but not T effector-memory cell development.
Castro I; Yu A; Dee MJ; Malek TR
J Immunol; 2011 Nov; 187(10):5170-82. PubMed ID: 21984699
[TBL] [Abstract][Full Text] [Related]
20. Protracted protection to Plasmodium berghei malaria is linked to functionally and phenotypically heterogeneous liver memory CD8+ T cells.
Berenzon D; Schwenk RJ; Letellier L; Guebre-Xabier M; Williams J; Krzych U
J Immunol; 2003 Aug; 171(4):2024-34. PubMed ID: 12902507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
